InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 03/07/2019 10:00:44 AM

Thursday, March 07, 2019 10:00:44 AM

Post# of 1454
News: $GTXI GTx and Oncternal Therapeutics Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies

-- Merger will combine Oncternal’s clinical stage oncology pipeline and expertise with GTx’s preclinical Selective Androgen Receptor Degrader (SARD) program for castration-resistant prostate cancer -- -- Conference call to be held today at 8:30 a.m. Eastern Time/5:30 a.m....

Got this from https://marketwirenews.com/news-releases/gtx-and-oncternal-therapeutics-enter-into-definitive-merger-agreement-to-create-nasdaq-listed-clinical-stage-company-developing-a-diverse-pipeline-of-novel-cancer-therapies-7817004.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News